Financial Statements - Solvay
Financial Statements - Solvay
Financial Statements - Solvay
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
90<br />
<strong>Solvay</strong> Global Annual Report 2008<br />
The ageing of trade receivables, other receivables, loans and other non-current assets is as follows:<br />
2007 EUR Million Total With<br />
writedown<br />
Not past<br />
due<br />
Of which receivables without write-down<br />
Less<br />
than<br />
30 days<br />
past due<br />
Between<br />
30 & 60<br />
days<br />
past due<br />
Between<br />
60 & 90<br />
days<br />
past due<br />
More than<br />
90 days<br />
past due<br />
Trade receivables 1 711 12 1 470 158 39 14 17<br />
Other current receivables 566 8 521 8 13 1 15<br />
Loans and<br />
other non-current assets<br />
252 0 237 6 0 0 9<br />
Total 2 529 20 2 228 171 52 15 42<br />
2008 EUR Million Total With<br />
writedown<br />
Not past<br />
due<br />
Of which receivables without write-down<br />
Less<br />
than<br />
30 days<br />
past due<br />
Between<br />
30 & 60<br />
days<br />
past due<br />
Between<br />
60 & 90<br />
days<br />
past due<br />
More than<br />
90 days<br />
past due<br />
Trade receivables 1 666 8 1 432 158 37 14 18<br />
Other current receivables 555 11 501 17 8 4 15<br />
Loans and<br />
other non-current assets<br />
273 1 264 0 0 1 8<br />
Total 2 495 19 2 197 175 45 19 41<br />
The other current receivables consist essentially of other receivables, deferred charges and accrued income.<br />
Other non-current assets consist essentially of pension fund surpluses and other amounts receivable after more than one year.<br />
The table below shows the evolution of write-downs on trade and fi nancial receivables and other non-current assets.<br />
EUR Million 2007 2008<br />
At 1 January -20 -17<br />
Net change 3 -56<br />
At 31 December -17 -73<br />
The net change of EUR 56 million is mainly related to write-downs recorded on fi nancial receivables of non-consolidated<br />
companies of the Innogenetics group recognized before the acquisition of the latter by <strong>Solvay</strong>.<br />
The management of credit risk is commented on in the “Management of Risks” section (page 107).